Figure 4From: Hyperdiploidy associated with T315I mutation in BCR-ABL kinase domain in an accelerated phase-chronic myeloid leukemia case ASO-PCR monitoring and corresponding sensitivity test for detected T315I mutation Post-nilotinib treatment. Line M, 1 kb DNA ladder; lines 1–8 patients ASO-PCR T315I wild-type primers; P, our patient; lines 9–16 ASO-PCR T315I mutated primers; and P*, our patient with T315I mutation.Back to article page